常山药业(300255)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

300255 常山药业

已收盘 04-28 15:00:00

{"stockData":{"symbol":"300255","market":"SZ","secType":"STK","nameCN":"常山药业","latestPrice":20.54,"timestamp":1745823822000,"preClose":20.58,"halted":0,"volume":9071500,"delay":0,"changeRate":-0.0019,"floatShares":916000000,"shares":919000000,"eps":-0.919,"marketStatus":"已收盘","change":-0.04,"latestTime":"04-28 15:00:00","open":20.6,"high":20.88,"low":20.27,"amount":187000000,"amplitude":0.0296,"askPrice":20.55,"askSize":247,"bidPrice":20.54,"bidSize":543,"shortable":0,"etf":0,"ttmEps":-0.919,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1745890200000},"marketStatusCode":5,"adr":0,"adjPreClose":20.58,"symbolType":"stock","openAndCloseTimeList":[[1745803800000,1745811000000],[1745816400000,1745823600000]],"highLimit":22.64,"lowLimit":18.52,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":919060878,"isCdr":false,"pbRate":10.4,"roa":"--","roe":"0.4%","epsLYR":-1.35,"committee":0.412316,"marketValue":18878000000,"turnoverRate":0.0099,"status":1,"floatMarketCap":18813000000},"requestUrl":"/m/hq/s/300255","defaultTab":"news","newsList":[{"id":"2529047822","title":"常山药业最新公告：预计2024年亏损加大 现预亏2.45亿元–2.55亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529047822","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529047822?lang=zh_cn&edition=full","pubTime":"2025-04-21 17:09","pubTimestamp":1745226572,"startTime":"0","endTime":"0","summary":"常山药业(300255.SZ)公告称，修正2024年度业绩预告，预计亏损加大。原预计亏损1.2亿元–1.8亿元，现预计亏损2.45亿元–2.55亿元。修正原因包括计提存货跌价准备约6,800万元和计提坏账准备约1,500万元。公司将进一步加强管理和信息披露质量。以上内容为证券之星据公开信息整理，由智能算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025042100022302.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","BK0239","300255","BK0172"],"gpt_icon":0},{"id":"2528048847","title":"【减肥药概念盘初活跃 金凯生科涨超10%】减肥药概念盘初活跃，金凯生科涨超10%，昊帆生物、华东医药、翰宇药业、百花医药、一品红、常山药业等跟涨。消息面上，礼来口服减肥药Orforglipron三期临床数据亮眼，股价涨逾14%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2528048847","media":"金融界","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2528048847?lang=zh_cn&edition=full","pubTime":"2025-04-18 09:26","pubTimestamp":1744939617,"startTime":"0","endTime":"0","summary":"减肥药概念盘初活跃，金凯生科涨超10%，昊帆生物、华东医药、翰宇药业、百花医药、一品红、常山药业等跟涨。消息面上，礼来口服减肥药Orforglipron三期临床数据亮眼，股价涨逾14%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"17136e9096e01d550821b3b9313a36c7","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/04/18092649644252.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LU0256863811.USD","LU2361045086.USD","LU1057294990.SGD","LU0203201768.USD","LU0256863902.USD","LU0708995401.HKD","IE00B2B36J28.USD","LU0122379950.USD","BK4599","IE0004445239.USD","LU2237443895.HKD","300199","BK0028","LU0456855351.SGD","IE00BFTCPJ56.SGD","LU1551013425.SGD","301393","LU2237443465.HKD","LU2265009873.SGD","LU2357305700.SGD","LU2112291526.USD","LU0238689110.USD","LU0385154629.USD","SGXZ99366536.SGD","IE00BJT1NW94.SGD","000963","BK0070","LU0097036916.USD","LU2491050154.USD","GB00BDT5M118.USD","LU1093756168.USD","LU1069344957.HKD","LU2237438978.USD","LU2461242641.AUD","LU1804176565.USD","LU1720051108.HKD","LU0820561818.USD","300255","SG9999017495.SGD","SGXZ57979304.SGD","301509","LU1868836914.USD","LU1983299246.USD","LU2324357040.USD","LU2023250504.SGD","600721","300723","SG9999014914.USD","LU2328871848.SGD"],"gpt_icon":0},{"id":"2514804557","title":"常山药业：请您仔细确认是否对本公司（常山药业）提问","url":"https://stock-news.laohu8.com/highlight/detail?id=2514804557","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514804557?lang=zh_cn&edition=full","pubTime":"2025-02-27 21:00","pubTimestamp":1740661231,"startTime":"0","endTime":"0","summary":"证券之星消息，常山药业(300255)02月27日在投资者关系平台上答复投资者关心的问题。投资者：董秘：您好！曾少贵，曾少强，曾少彬仨人是否参与公司管理？常山药业董秘：您好，请您仔细确认是否对本公司（常山药业）提问。以上内容为证券之星据公开信息整理，由智能算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025022700039578.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0172","BK0070","300255"],"gpt_icon":0},{"id":"2513718759","title":"常山药业财务造假案背后：核心产品集采失标致业绩大幅下滑","url":"https://stock-news.laohu8.com/highlight/detail?id=2513718759","media":"微博财经-财道工作室","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513718759?lang=zh_cn&edition=full","pubTime":"2025-02-24 10:39","pubTimestamp":1740364740,"startTime":"0","endTime":"0","summary":"公告显示，常山药业2022年以现金方式向并未实际提供旅行服务的某旅行社支付差旅费，导致虚列销售费用、管理费用合计373.29万元。该年，肝素类药品首次被纳入第八批药品集中采购，但常山药业核心产品低分子量肝素钙注射液并未进入集采，仅在部分地区执行省级集采，导致该产品2023年销量同比2022年大幅下滑46.51%，叠加去库存挑战，公司年度营收大幅下降，创下12.4亿元的巨额亏损。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/wbstock/2025-02-24/doc-inemqazp0140013.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["300255","BK0070","BK0172","BK0239"],"gpt_icon":0},{"id":"2513252138","title":"常山药业：公司在定期报告中介绍了牛、羊源肝素的业务情况","url":"https://stock-news.laohu8.com/highlight/detail?id=2513252138","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513252138?lang=zh_cn&edition=full","pubTime":"2025-02-21 17:30","pubTimestamp":1740130236,"startTime":"0","endTime":"0","summary":"证券之星消息，常山药业(300255)02月21日在投资者关系平台上答复投资者关心的问题。投资者：您好：董秘   请介绍清真肝素钠的销售情况常山药业董秘：尊敬的投资者，您好。为发挥公司在猪源肝素的技术优势，拓展公司业务，公司开展了牛源肝素和羊源肝素的研发，公司在定期报告中介绍了牛、羊源肝素的业务情况。目前该业务占公司收入比例不大。公司将持续推进牛、羊源肝素的研发、销售工作，以实现规模化发展。感谢您的关注。以上内容为证券之星据公开信息整理，由智能算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025022100029788.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300255","BK0172","BK0070","BK0239"],"gpt_icon":0},{"id":"2512445762","title":"常山药业（300255）2月19日主力资金净卖出7232.69万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512445762","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512445762?lang=zh_cn&edition=full","pubTime":"2025-02-20 09:20","pubTimestamp":1740014435,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2025年2月19日收盘，常山药业报收于20.58元，下跌1.86%，换手率4.23%，成交量38.78万手，成交额8.02亿元。近5日资金流向一览见下表：常山药业融资融券信息显示，融资方面，当日融资买入8286.03万元，融资偿还6935.57万元，融资净买入1350.46万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025022000007895.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","BK0239","300255","BK0172"],"gpt_icon":0},{"id":"2512142686","title":"常山药业：公司无法获取2月14日收盘后的股东名册","url":"https://stock-news.laohu8.com/highlight/detail?id=2512142686","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512142686?lang=zh_cn&edition=full","pubTime":"2025-02-19 12:00","pubTimestamp":1739937639,"startTime":"0","endTime":"0","summary":"证券之星消息，常山药业(300255)02月19日在投资者关系平台上答复投资者关心的问题。投资者：董秘您好，能方便披露一下2月14日收盘后股东户数的变化情况吗常山药业董秘：尊敬的投资者，您好。公司无法获取2月14日收盘后的股东名册。感谢您的关注。以上内容为证券之星据公开信息整理，由智能算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025021900018007.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300255","BK0070","BK0239","BK0172"],"gpt_icon":0},{"id":"2512173621","title":"常山药业（300255）2月18日主力资金净买入9572.29万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512173621","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512173621?lang=zh_cn&edition=full","pubTime":"2025-02-19 09:01","pubTimestamp":1739926894,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2025年2月18日收盘，常山药业报收于20.97元，上涨11.07%，换手率6.52%，成交量59.67万手，成交额12.34亿元。近5日资金流向一览见下表：常山药业融资融券信息显示，融资方面，当日融资买入1.09亿元，融资偿还9519.5万元，融资净买入1412.27万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025021900008418.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0070","BK0172","300255"],"gpt_icon":0},{"id":"2512490901","title":"A股创新药板块探底回升，常山药业涨超12%，诺诚健华涨超6%，海创药业、一品红、益方生物跟涨。","url":"https://stock-news.laohu8.com/highlight/detail?id=2512490901","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512490901?lang=zh_cn&edition=full","pubTime":"2025-02-18 10:47","pubTimestamp":1739846858,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["159982","399300","BK0172","300255","BK1574","159992","06978","BK0239","300723","688302","688428","BK0070","09969","BK1161","688382"],"gpt_icon":0},{"id":"2511659728","title":"常山药业：公司正在积极推进上述工作","url":"https://stock-news.laohu8.com/highlight/detail?id=2511659728","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511659728?lang=zh_cn&edition=full","pubTime":"2025-02-14 16:30","pubTimestamp":1739521830,"startTime":"0","endTime":"0","summary":"证券之星消息，常山药业02月14日在投资者关系平台上答复投资者关心的问题。或艾本那肽上市后的销售渠道优势，请回复，谢谢！","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025021400025938.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","BK0172","BK0239","300255"],"gpt_icon":0},{"id":"2511684689","title":"常山药业财务造假案警示录：集采寒冬下的灰色交易与投资陷阱","url":"https://stock-news.laohu8.com/highlight/detail?id=2511684689","media":"新浪证券","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511684689?lang=zh_cn&edition=full","pubTime":"2025-02-14 11:06","pubTimestamp":1739502360,"startTime":"0","endTime":"0","summary":"　　2月8日，财政部一则行政处罚公告将常山药业推至风口浪尖。公告披露，该公司2022年通过虚构差旅费支出，向未提供服务的旅行社支付现金373.29万元，涉嫌虚列销售费用及管理费用。常山药业却以现金形式完成全部373万元支付，明显违反财务规范。常山药业顶风作案表明，在“两票制”压缩传统回扣空间后，现金差旅费正成为新型灰色交易载体。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/s/2025-02-14/doc-inekmitn6970778.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0070","300255","BK0239","BK0172"],"gpt_icon":0},{"id":"2511351680","title":"常山药业最新公告：CSCJC3456片Ⅰ期临床试验首例受试者入组","url":"https://stock-news.laohu8.com/highlight/detail?id=2511351680","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511351680?lang=zh_cn&edition=full","pubTime":"2025-02-13 16:54","pubTimestamp":1739436886,"startTime":"0","endTime":"0","summary":"常山药业公告称，公司与控股子公司常山凯捷健共同研发的创新药CSCJC3456片Ⅰ期临床试验已完成首例受试者入组。该药物是一种小分子多靶点酪氨酸激酶抑制剂，具有抗肿瘤作用。然而，该药物需经过后续临床试验并获相关部门审批后才能上市销售，存在研发周期长、投入大、风险高等不确定性。以上内容为证券之星据公开信息整理，由智能算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025021300029009.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300255","BK0070","03347","BK1583","BK0172","BK1141","BK0239","BK1576"],"gpt_icon":0},{"id":"2511597017","title":"【常山药业：CSCJC3456片Ⅰ期临床试验首例受试者入组】常山药业公告，公司与控股子公司常山凯捷健生物药物研发（河北）有限公司开展的创新药CSCJC3456片Ⅰ期临床试验，于近日完成首例受试者入组。CSCJC3456片是由公司及常山凯捷健研发的靶向抗肿瘤药物，通过选择性抑制FGFR/KIT/RET/TRK等靶点而发挥抑制肿瘤细胞增殖、抑制新生血管生成、促进肿瘤凋亡的作用。临床前研究结果显示，CSCJC3456对多种癌症均显示良好的抗肿瘤作用，具有潜力在后续临床试验中展现出良好的治疗效果。","url":"https://stock-news.laohu8.com/highlight/detail?id=2511597017","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511597017?lang=zh_cn&edition=full","pubTime":"2025-02-13 15:57","pubTimestamp":1739433467,"startTime":"0","endTime":"0","summary":"常山药业公告，公司与控股子公司常山凯捷健生物药物研发（河北）有限公司开展的创新药CSCJC3456片Ⅰ期临床试验，于近日完成首例受试者入组。CSCJC3456片是由公司及常山凯捷健研发的靶向抗肿瘤药物，通过选择性抑制FGFR/KIT/RET/TRK等靶点而发挥抑制肿瘤细胞增殖、抑制新生血管生成、促进肿瘤凋亡的作用。临床前研究结果显示，CSCJC3456对多种癌症均显示良好的抗肿瘤作用，具有潜力在后续临床试验中展现出良好的治疗效果。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/13155748136756.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1141","BK1576","300255","BK1583","BK1574","03347","159992","159839","06978","BK0239","BK0070","BK0172","BK1161"],"gpt_icon":0},{"id":"2511690145","title":"常山药业：因虚列费用遭财政部处罚， 巨亏12亿后仍预亏","url":"https://stock-news.laohu8.com/highlight/detail?id=2511690145","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511690145?lang=zh_cn&edition=full","pubTime":"2025-02-13 11:33","pubTimestamp":1739417580,"startTime":"0","endTime":"0","summary":"　　近日，财政部官网发布《中华人民共和国财政部财会监督检查公告》，公示2023年对41家会计师事务所开展执业质量检查，及延伸检查89户企业的会计信息质量结果，并发布了十起典型案例。其中，常山药业因虚列销售费用、管理费用被通报。涉及的事由即为常山药业于2024年3月因2022年度通过大额现金支付虚列支出被财政部行政处罚。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2025-02-13/doc-inekieuk8510731.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","BK0070","BK0172","300255"],"gpt_icon":0},{"id":"2510936453","title":"常山药业（300255）2月11日主力资金净卖出5504.12万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510936453","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510936453?lang=zh_cn&edition=full","pubTime":"2025-02-12 09:20","pubTimestamp":1739323229,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2025年2月11日收盘，常山药业报收于18.66元，下跌3.81%，换手率2.03%，成交量18.61万手，成交额3.5亿元。近5日资金流向一览见下表：常山药业融资融券信息显示，融资方面，当日融资买入3308.59万元，融资偿还3493.0万元，融资净偿还184.41万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025021200007456.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","BK0172","300255","BK0239"],"gpt_icon":0},{"id":"2509039643","title":"财政部发布财会监督检查典型案例，涉A股公司美凯龙和常山药业","url":"https://stock-news.laohu8.com/highlight/detail?id=2509039643","media":"银柿财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509039643?lang=zh_cn&edition=full","pubTime":"2025-02-08 18:30","pubTimestamp":1739010604,"startTime":"0","endTime":"0","summary":"2月8日，财政部在官网发布《中华人民共和国财政部财会监督检查公告》表示，2023年，财政部组织有关监管局，对41家备案从事证券服务业务的会计师事务所开展执业质量检查，并延伸检查89户企业的会计信息质量。同时，财政部在官网披露了十起典型案例。银柿财经注意到，其中涉及两家A股上市公司。财政部依据《中华人民共和国会计法》，给予该公司罚款5万元的行政处罚。与美凯龙类似，常山药业近年的盈利水平也出现下滑。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250208183018a23e1af1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250208183018a23e1af1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["300255","BK0070","601828","BK0210","BK0172","159982","399300","BK0239"],"gpt_icon":0},{"id":"2509624417","title":"化妆品概念6日主力净流出1959.21万元，常山药业、珀莱雅居前","url":"https://stock-news.laohu8.com/highlight/detail?id=2509624417","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509624417?lang=zh_cn&edition=full","pubTime":"2025-02-06 15:41","pubTimestamp":1738827689,"startTime":"0","endTime":"0","summary":"2月6日，化妆品概念上涨1.25%，今日主力资金流出1959.21万元，概念股49只上涨，7只下跌。主力资金净流出居前的分别为常山药业（2381.78万元）、珀莱雅（1585.9万元）、朗姿股份（1569.35万元）、福瑞达（1169.48万元）、华润三九（1097.6万元）。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502061545159619cfc2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502061545159619cfc2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1997245177.USD","LU2460026573.USD","603605","300255","BK0229","LU0593848301.USD","BK0070","BK0172","LU1146622755.USD","LU1820825898.SGD","LU1997245094.SGD","BK0239"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1745839708932,"stockEarnings":[{"period":"1week","weight":0.0311},{"period":"1month","weight":0.042},{"period":"3month","weight":0.0976},{"period":"6month","weight":-0.1457},{"period":"1year","weight":0.7485},{"period":"ytd","weight":0.0295}],"compareEarnings":[{"period":"1week","weight":0.0056},{"period":"1month","weight":-0.0219},{"period":"3month","weight":0.013},{"period":"6month","weight":-0.0014},{"period":"1year","weight":0.0793},{"period":"ytd","weight":-0.0169}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"河北常山生化药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"35570人(较上一季度增加1.10%)","perCapita":"25749股","listingDate":"2011-08-19","address":"河北省石家庄市正定县中国(河北)自由贸易试验区正定片区高新技术产业开发区南区梦龙街71号","registeredCapital":"91906万元","survey":"　　河北常山生化药业股份有限公司主营业务是研发、生产和销售治疗心脑血管疾病药物。公司主要产品有普通肝素原料药、低分子肝素原料药、低分子肝素制剂、普通肝素制剂。公司是国内少数拥有完整肝素产品产业链、能够同时从事肝素粗品、肝素原料药和肝素制剂药品研发、生产和销售的领军企业之一。","listedPrice":28},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"常山药业(300255)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供常山药业(300255)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"常山药业,300255,常山药业股票,常山药业股票老虎,常山药业股票老虎国际,常山药业行情,常山药业股票行情,常山药业股价,常山药业股市,常山药业股票价格,常山药业股票交易,常山药业股票购买,常山药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"常山药业(300255)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供常山药业(300255)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}